Kirk Taylor Announces Postdoctoral Research Opportunity on Megakaryocyte and Platelet Communication at University of Reading
Kirk Taylor, Lecturer in Biomedical Sciences in the University of Reading, shared an insightful post on LinkedIn:
“Pleased to share that we are looking to recruit a postdoc to join the Reading Platelet Group.
This is an exciting project that will explore how megakaryocytes and platelets communicate using advanced microscopy and flow cytometry approaches.
The project will dissect and characterise intercellular communication pathways to build a model of how megakaryocytes and platelets interact. The experimental design will increase the complexity of interactions and the role of control mechanisms in 2D, 3D, and 4D. Using established in vivo approaches, the post holder will design and conduct assays to model thrombus formation under physiologically relevant conditions.
The postholder is expected to be a central link in the communication of staff involved in the project. In particular, this includes collaboration with a second PDRA employed by the project responsible for theoretical and computational developments. Strong communication skills and an ability to work in a multidisciplinary environment are hence essential.”
Apply here:
Stay updated with Hemostasis Today.
-
Feb 2, 2026, 17:54Danny Gaskin: Nominations are Open for the BBTS Transfusion Practitioner Special Interest Group Award 2026
-
Feb 2, 2026, 17:44Important Webinar on Care for Patients with iTTP – ISTH
-
Feb 2, 2026, 17:21Tagreed Alkaltham: Some Risks Don’t Look Like Risks in Healthcare
-
Feb 2, 2026, 17:16Sifat Jubaira: Effect of Prolonged Tourniquet Application
-
Feb 2, 2026, 17:14Vivek Mahto: Understanding Deep Vein Thrombosis – Causes, Symptoms, and Prevention
-
Feb 2, 2026, 17:08Tareq Abadl: Heparin vs Warfarin
-
Feb 2, 2026, 17:07Mary Cushman: New Research on Aspirin Use in Pregnancy and Stroke Risk in Offspring
-
Feb 2, 2026, 16:52Aravind Palraj: Young Stroke is Never Just Stroke
-
Feb 2, 2026, 16:48Seyed Mohsen Jahromi Moghadam: Antithrombotic Therapy After Transcatheter Structural Heart Interventions